Teva acquires Cephalon
The combined company will have its presence established in more than 60 countries and generated nearly $20bn revenues on a pro-forma basis for the twelve months ended June
AtomVie Global Radiopharma has opened a purpose-built radiopharmaceutical manufacturing facility in Hamilton, Ontario, Canada, with an investment of more than $160m.